Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
45.54
+0.47 (1.04%)
At close: Sep 26, 2025, 4:00 PM EDT
45.87
+0.33 (0.72%)
After-hours: Sep 26, 2025, 6:08 PM EDT
Sanofi Revenue
Sanofi had revenue of 10.74B EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 45.74B, up 15.65% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.74B EUR
Revenue Growth
+15.65%
P/S Ratio
2.07
Revenue / Employee
551,871 EUR
Employees
82,878
Market Cap
111.44B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SNY News
- 1 day ago - A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff - Seeking Alpha
- 1 day ago - Sanofi Expands Insulin Savings Program To Cover All US Patients - Benzinga
- 1 day ago - Sanofi to offer all insulin products for $35 per month in US - Reuters
- 1 day ago - Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US - PRNewsWire
- 3 days ago - French court orders Sanofi to pay $177 million for anti-competitive behaviour - Reuters
- 4 days ago - Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation - GlobeNewsWire
- 4 days ago - Press release: Availability of the Q3 2025 Aide mémoire - GlobeNewsWire
- 4 days ago - Sanofi (SAN:CA) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha